Blog
How Japan Holds Down Health Costs With One National Fee Schedule
Japan has covered everyone since 1961 with thousands of insurers and one government price list revised every two years. Here is how that price list works and what it costs.
Somewhere in a Tokyo ministry building, every second year, a committee of insurers, doctors, hospital representatives and public members sits down with a document that runs to thousands of entries. Each entry is a procedure, a test, a visit or a drug, and next to each is a number of points. One point is worth ten yen. Every clinic and hospital in Japan, from a mountain village practice to a university medical center, gets paid from that same list, by every insurer, for every patient. The committee's job is to decide which numbers go up and which go down. It is one of the least glamorous institutions in the world, and it is a big part of why a country with the oldest population of any large nation spends far less on health care per person than the United States while covering everyone. Japan reached universal coverage in 1961, four years before America created Medicare. It did it without a single payer. It did it with a price list.
In short: Japan covers its whole population through many separate insurers, but all of them pay doctors and hospitals the same prices, set nationally and revised every two years. That single fee schedule gives the government a powerful lever over total spending. The trade-offs include short appointments and long hospital stays, but the core lesson for the United States is that common prices matter more than the number of insurers.
Universal coverage in 1961
Japan's health insurance history begins earlier than most Americans realise. A Health Insurance Act for employees was passed in 1922, influenced by the German model, and a National Health Insurance law for farmers and the self-employed followed in 1938. After the Second World War, large gaps remained: many people outside formal employment were still uninsured.
In 1958 the National Health Insurance Act was revised to require every municipality to run an insurance program for residents not covered through work. By 1961 the system covered the whole population. The Japanese term for it, kaihoken, roughly "insurance for all", became a point of national pride.
Like Germany, Japan reached universality by filling gaps rather than replacing what existed. The result is a system that looks complicated from the outside.
Thousands of insurers, one rulebook
There are several main families of insurance in Japan.
Large companies run their own health insurance societies for employees and their families. Workers at smaller firms are covered by a big national association. Civil servants and teachers have mutual aid associations. Farmers, the self-employed, retirees under 75 and the unemployed join the National Health Insurance program run by local governments, now with prefectures sharing responsibility. Since 2008 people aged 75 and older have their own separate system, funded partly by contributions from the other insurers and by taxes.
Counted together, there are thousands of separate insurers. Contributions differ: employees pay a percentage of their wages shared with employers; people in the municipal program pay premiums set by local formulas. Insurers whose members are older and poorer receive transfers from government and from other insurers.
What ties this patchwork together is the national fee schedule. Insurers do not negotiate their own prices with hospitals. A clinic does not charge one insurer more than another. And, with narrow exceptions, a provider cannot charge a patient more than the official price for covered care, or mix covered and uncovered services freely in the same course of treatment. That last rule, a ban on balance billing, closes the door through which costs escape in many other systems.
How the price list is set
The fee schedule is revised every two years. The process runs through the Ministry of Health, Labour and Welfare and a body known as the Central Social Insurance Medical Council, usually called Chuikyo, which includes payers, providers and members representing the public interest.
The revision happens in two stages.
First, the overall rate. The cabinet decides the total percentage change for the fee schedule as part of the national budget. This is the big political fight: doctors' organizations push for increases, the finance ministry pushes for restraint. The result is a single number, sometimes a small increase, sometimes a cut, that sets the direction of spending.
Second, the detailed prices. Within that envelope, Chuikyo adjusts individual items. If the ministry sees that some procedure is being performed far more often than expected, or that a scan has become cheaper to provide, the price can be cut. If policymakers want more home care, or more support for doctors in rural areas, or more hours from pediatricians, the price for those services can rise. Drug prices are surveyed and usually reduced at each revision to track what pharmacies actually pay.
This is the crucial mechanism. Because every provider is paid off the same list, a change to the list changes behaviour across the entire country at once. If spending on a particular test is growing too fast, the government does not need to argue with thousands of insurers. It lowers the price. Volume may rise somewhat in response, and the ministry watches for that, but over time the national total stays on a much tighter leash than in the United States.
The famously cheap MRI
The clearest illustration is imaging. Japan has more MRI and CT scanners per person than almost any other country. In American health economics, that would normally be a recipe for runaway costs: more machines usually mean more scans and higher bills.
In Japan the fee schedule sets the price of a scan at a level far below typical American charges, and the price has been cut repeatedly as the machines became common. Hospitals and clinics adapted by keeping their own costs low and running the machines often, because even at those prices a scanner was worth having. Patients get easy access to imaging; the country does not go broke doing it.
The pattern repeats across the system. Japan does not hold down spending by limiting how often people see doctors. Japanese people visit doctors far more often than Americans do. It holds down spending mainly by holding down prices.
What patients pay and what they get
Patients in Japan pay a share of the cost when they get care, generally 30 percent for working-age adults, with lower shares for young children and older people. That sounds steep. It is softened by a monthly cap on out-of-pocket spending that scales with income, so that a serious illness does not bankrupt a household. Low-income patients have lower caps.
Patients can also go to almost any clinic or hospital they choose, without a referral from a gatekeeper for most care. There are no networks to check. A card from any insurer works at any provider.
By most broad measures the results are strong. Japanese life expectancy is among the highest in the world. Infant mortality is very low. Japan spends a smaller share of its economy on health than the United States does, despite having a much older population, and older populations need more care.
Why the doctors put up with it
An American reader may wonder why Japanese doctors, who have a strong professional association, accept a system in which the government sets every price. The answer is that the system gives them a seat at the table and a stable income in exchange.
Physicians are represented on the council that sets the detailed prices, and the national medical association has long been one of the most influential lobbies in Japanese politics. Each revision is a negotiation, not an order. Doctors know the rules, know when they will change, and can plan around them. They do not have to employ staff to argue with insurers about whether a service will be paid, because if it is on the list at a set price, it is paid.
Many clinics in Japan are owned by the physicians who work in them, and some also dispense medicines, which historically gave doctors income from drug sales. Policy has pushed to separate prescribing from dispensing, and drug prices are cut at revisions, which has reduced that income over time. Doctors' groups complain about these changes, loudly. But they negotiate within the system rather than against it.
The trade-offs, without spin
No system is free of problems, and Japan's are well known to Japanese doctors and patients.
Short appointments. Because the fee schedule pays a modest amount per visit and more visits mean more revenue, many clinics see a lot of patients quickly. Complaints about brief consultations after long waits in crowded clinics are common.
Long hospital stays. Japan has historically had many hospital beds and long average stays compared with other rich countries, partly because hospitals filled the role that nursing homes and long-term care play elsewhere. Japan created a separate long-term care insurance system in 2000, and policy has pushed to shorten stays, but the pattern has been slow to change.
Financial pressure from ageing. Japan's population is old and shrinking. The working-age contributors who fund the system are a smaller share of the population every year. The government has raised cost-sharing for some older patients and tightened prices. How Japan pays for care as its population ages is one of its central political questions.
Provider frustration. Doctors' groups argue that repeated price cuts squeeze small clinics and push hospitals into deficit, and that the system relies on physicians working very long hours. Japan has adopted work-hour limits for doctors as part of broader labour reforms, which raises its own staffing questions.
None of this has led to serious proposals to abandon the fee schedule. The fights are about the level of prices and how to share costs, not the principle that everyone is paid from one list.
The American lesson: it is the prices
For a generation, the leading explanation among health economists for why Americans spend so much more on health care than people in other rich countries has been summed up in a phrase from a widely cited 2003 paper in the journal Health Affairs by Gerard Anderson, Uwe Reinhardt and colleagues: it's the prices. Americans do not, on average, go to the doctor more often or spend more days in hospital. They pay much more for each visit, scan, procedure and drug.
Japan is the cleanest proof of the point. It has more insurers than the United States, more scanners per person, more doctor visits per person and an older population, and it still spends much less, because the price of each service is set nationally.
The United States already has something like a national fee schedule: Medicare's. Medicare sets prices for physician services and hospital stays through formulas and annual rules. But Medicare's prices apply only to Medicare. Private insurers negotiate their own prices, which are typically far higher, especially at hospitals that dominate their regional markets.
It is worth noticing that Medicare's prices are already set through a process that looks a little like Japan's. Each year the federal agency that runs Medicare proposes payment updates, publishes them for public comment and finalizes them. A committee convened by the American Medical Association, known as the RUC, recommends values for physician services, a role critics say gives specialists too much influence over what primary care is worth. The machinery for public price-setting exists. What the United States lacks is the decision to apply it to everyone.
There are several ways an American version of the Japanese idea could work, and here I am making an argument:
- Cap private prices at a multiple of Medicare. Some states have done this for public employee plans or public options. Montana, for example, moved its state employee plan to reference-based prices tied to Medicare.
- All-payer rate setting. Maryland has set hospital rates for all payers for decades, under a special arrangement with the federal government, and has since moved to global hospital budgets.
- Let Medicare negotiate more drug prices. The Inflation Reduction Act of 2022 gave Medicare authority to negotiate the prices of some high-cost drugs for the first time, a modest step in the direction Japan took long ago.
Opponents argue that lower prices will drive hospitals out of business, especially in rural areas, and reduce investment in new treatments. Those concerns are legitimate. Japan answers them partly by adjusting prices on purpose, raising payments for things in short supply, and that is the right answer here too. Price setting does not have to be blunt. It has to be done by someone accountable, in public, on a schedule.
What you can do
The price of care is set somewhere. The question is whether it is set in public, by people you can hold accountable, or behind closed doors in negotiations you never see.
- Watch how health costs hit household budgets. The affordability topic page follows premiums, deductibles, drug prices and medical debt alongside other costs families face.
- Weigh in on Medicare payment rules. Medicare's physician and hospital payment rules are proposed and opened for public comment each year. The federal comment page lists rules open for comment, with the soonest deadlines first, and walks through how to write a useful comment.
- Ask your state legislators about price caps. Many of the boldest experiments in hospital pricing happen in statehouses. Look up your state legislators and members of Congress, with their contact details and recent votes, on the representatives page.
- Follow the broader push for coverage. The health care for all page gathers reporting on public options, single-payer bills and drug pricing.
- Share your bills. Patient advocates and local reporters use real bills to show what hospitals charge. If you are comfortable doing so, an itemised bill shared with a patient advocacy group can help build the case for public prices.